Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Establish the maximum tolerated dose (MTD) of the study drug.
United States: Food and Drug Administration
|University of Texas, M.D. Anderson Cancer Center||Houston, Texas 77030|
|Emory University School of Medicine, Winship Cancer Center||Atlanta, Georgia 30322|